Ji Jiang
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Analytical Chemistry top 1%
- Analytical Methods in Pharmaceuticals
Papers in
-
- Analytical Methods in Pharmaceuticals 62
- Pharmacology 39
- Pharmacogenetics and Drug Metabolism 37
- Co-authors
- Pei Hu (128 shared papers)Qian Zhao (44 shared papers)Dongyang Liu (34 shared papers)Hongyun Wang (19 shared papers)Sheng Feng (5 shared papers)Hongyun Wang (15 shared papers)Jing Lu (2 shared papers)Wen Zhong (13 shared papers)
- Journals
- Journal of Chromatography B (18 papers)Journal of Pharmaceutical and Biomedical Analysis (13 papers)Bioanalysis (10 papers)Biomedical Chromatography (8 papers)Chromatographia (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ji Jiang
188 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 111
- Pharmacology 332
- Analytical Chemistry 352
- Anesthesiology and Pain Medicine 147
- Reproductive Medicine 179
- Pediatrics, Perinatology and Child Health 124
Countries citing papers authored by Ji Jiang
This map shows the geographic impact of Ji Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Jiang more than expected).
Fields of papers citing papers by Ji Jiang
This network shows the impact of papers produced by Ji Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Jiang. The network helps show where Ji Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ji Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 193 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 230 | |
| 2 | 2020 | 89 | |
| 3 | 2016 | 75 | |
| 4 | 2018 | 66 | |
| 5 | 2004 | 61 | |
| 6 | 2009 | 58 | |
| 7 | 2018 | 54 | |
| 8 | 2008 | 52 | |
| 9 | 2012 | 50 | |
| 10 | 2016 | 47 | |
| 11 | 2002 | 42 | |
| 12 | 2010 | 41 | |
| 13 | Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer. | 2011 | 36 |
| 14 | 2017 | 33 | |
| 15 | 2020 | 32 | |
| 16 | 2004 | 31 | |
| 17 | 2012 | 30 | |
| 18 | 2015 | 30 | |
| 19 | 2009 | 29 | |
| 20 | 2010 | 28 |
About Ji Jiang
Ji Jiang is a scholar working on Analytical Chemistry, Pharmacology, Pediatrics, Perinatology and Child Health, Hematology and Endocrinology, Diabetes and Metabolism, having authored 193 papers that have together received 2.5k indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (62 papers), Pharmacogenetics and Drug Metabolism (37 papers), Pharmaceutical studies and practices (14 papers), Lung Cancer Treatments and Mutations (9 papers), Diabetes Treatment and Management (8 papers), Biosimilars and Bioanalytical Methods (8 papers), Cholesterol and Lipid Metabolism (7 papers) and Synthesis and biological activity (7 papers). The work is most often cited by research in Pharmacology (332 citations), Analytical Chemistry (352 citations), Anesthesiology and Pain Medicine (147 citations), Reproductive Medicine (179 citations) and Pediatrics, Perinatology and Child Health (124 citations). Ji Jiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Pei Hu, Qian Zhao, Dongyang Liu, Hongyun Wang, Sheng Feng, Hongyun Wang, Jing Lu, Wen Zhong, Xia Chen and Fenlai Tan. Their work appears in journals such as Journal of Chromatography B, Journal of Pharmaceutical and Biomedical Analysis, Bioanalysis, Biomedical Chromatography and Chromatographia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.